Jeffrey Anderson was appointed our President in March 2019. Prior to that he served as our Senior Vice President of Clinical and Regulatory affairs since December 2013, overseeing all aspects of the clinical evaluation and regulatory approval of the Company’s products as well as the commercial launch in several key markets. Previously, he served as our Vice President of Clinical and Regulatory affairs from 2004 to 2008, and again from February 2011 until his promotion to Senior Vice President. He has over 25 years of experience in the medical device industry, including his positions of Vice President of Clinical & Regulatory Affairs and Vice President of Research & Development for Neomend, a biomedical device company engaged in the development and commercialization of surgical wound healing products, where he served from October 2008 through February 2011. Additionally, Mr. Anderson has held senior positions at Abbott Vascular, Jomed, CRS Clinical Research, and Medtronic. He received his B.S. in Physics from California State University at Fullerton.
Jessica Earley was appointed our Vice President of Operations and Product Development in January 2019. She has been with REVA since 2003 and directed the scaffold development program since 2015 and operations since 2016. In her 18 years of industry experience, she has held engineering, program management and operational management positions in the pharmaceutical and medical device industries. Jessica holds a Chemical Engineering degree from the University of New Hampshire.
Doug Henson joined us as our Director of Accounting and Administration on November 15, 2021. He has over 20 years of accounting and financial management. Most recently Doug was Senior Director of Accounting and Controller of La Jolla Institute. Earlier in his career Doug held various finance leadership positions at Ludwig Institute, Audatex, Newland Real Estate Group, and Ernst and Young. Doug has a Bachelor of Accountancy degree from University of San Diego and is a licensed and active CPA in the State of California.
Naomi Gong joined us as our Vice President of Regulatory Affairs and Quality Assurance in June 2022. She has over 25 years of experience in regulatory and quality management in the medical device sector. Most recently, Naomi was Vice President of Regulatory Affairs at Rebound Therapeutics, a start-up acquired by Integra LifeSciences. She has also held regulatory leadership roles at MicroVention-Terumo where she obtained numerous product approvals for implants, combination products, and peripheral/neurovascular devices. Naomi holds a degree in Electrical Engineering from the University of California, Los Angeles.